Mr William Edward Pickeral Jr, LMSW | |
10605 Concord St, Kensington, MD 20895-2504 | |
(301) 231-9001 | |
(301) 231-9001 |
Full Name | Mr William Edward Pickeral Jr |
---|---|
Gender | Male |
Speciality | Social Worker - Clinical |
Location | 10605 Concord St, Kensington, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508574542 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr William Edward Pickeral Jr, LMSW 7533 Main St Ste 1f, Sykesville, MD 21784-5308 Ph: (410) 935-5140 | Mr William Edward Pickeral Jr, LMSW 10605 Concord St, Kensington, MD 20895-2504 Ph: (301) 231-9001 |
News Archive
The US Food and Drug Administration has expanded the approved indication for Exelon Patch (rivastigmine transdermal system) to include the treatment of people with severe Alzheimer's disease with Exelon Patch 13.3mg/24h.
New research from Rockefeller University, performed in collaboration with scientists at Duke University in North Carolina, reveals for the first time that this extreme variability in peopl's perception of androstenone is due in large part to genetic variations in a single odorant receptor called OR7D4.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
Spectrum Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S. Food & Drug Administration for SPI-014 (previously referred to as RENAZORB), a second-generation lanthanum-based nanoparticle phosphate binding agent, that has the potential to treat hyperphosphatemia in patients with Stage 5 chronic kidney disease, or end-stage renal disease (ESRD).
› Verified 9 days ago
Arlene Paulson, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 10605 Concord St Ste 207, Kensington, MD 20895 Phone: 301-231-9001 | |
Ms. Regina S Connor, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10500 Summit Ave, Kaiser Permanente Summit Behavioral Health Center, Kensington, MD 20895 Phone: 301-897-2500 | |
Shannon Golub, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3930 Knowles Ave Ste 200, Kensington, MD 20895 Phone: 513-702-4366 | |
Reuben Rosen, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3930 Knowles Ave Ste 200, Kensington, MD 20895 Phone: 240-801-5843 | |
Mrs. Elbereth Margaux Lunn, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10605 Concord St Ste 207, Kensington, MD 20895 Phone: 301-231-9001 | |
Ms. Karen Prince, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10400 Connecticut Ave, Suite 204, Kensington, MD 20895 Phone: 301-933-4588 | |
Melanie Rabkin, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10605 Concord St, #207, Kensington, MD 20895 Phone: 301-651-4275 |